No problem. And the Company will also leverage Cologuard to apply to the 1.4 million Crohn's Disease sufferers (inflammatory bowel disease) in which the colons are so inflamed that an optical colonoscopy by a GI doc is just not realistic. These poor souls have to undergo random biopsies (20-30) annually of their colon, as the standard of care. Cologuard will be perfect for these 1.4 million people. And anyone else (for that matter) that do not wish to have to take a full day off work and undergo anesthesia for a colonoscopy, not too mention spending the night before sitting on the can for 2 hours straight drinking that horrible bowel cleansing solution.
And their partner (Mayo Clinic) is already at work on identifying methylation bio-markers in stool for Pancreatic Cancer. And as we all know, coming across PanC is usually done late in the "game" and winds up being a Death Sentence.
Can you elaborate? I see there isn't much change in theta from May to October, but I can still purchase near-unity delta at a discount with say a $6 OCT13 long call. I give up a bit of breakeven, but if it really pops . . . ???
Yeah, I traded these about 9 years ago. That often seemed to be the case in hindsight. The market had a hard time pricing vol high enough. We noticed this and Don87109 put on an experimental trade. We liked to test things with real money. He bought a 2 lot ATM straddle, I believe, for a ridiculous price of 18 ea. Geez, I can't remember if it was a 30 or 40 stock, but it seemed absurd. Very high vol. He got 20 ea. for the straddles, if I recall correctly, but he had to wait. Didn't prove anything, just interesting.
optionality.. and i agree.. i mean.. what would vols have to be for it to go to 25 in the front month.. haha
I think it's universally accepted that the trial will succeed. The discount to success is risk premium and execution risk. I would trade vol as a proxy for direction. Short vol if you are bullish, long vol if you are bearish. The distribution is pricing rich on the upside and cheap on the downside. My opinion only.
The market-cap is only $670 million. There are 5.8 million shorts out there that have been betting on management not being able to execute. Thus far, they have met their guidance every step of the way.... and have only been one month behind their "time-line" that was offered over 2 years ago. In the past, if you have bet against CEO Kevin Conroy you have lost.